Yamamoto N, Naraparaju V R, Srinivasula S M
Laboratory of Cancer Immunology and Molecular Biology, Albert Einstein Cancer Center, Philadelphia, Pennsylvania 19141, USA.
AIDS Res Hum Retroviruses. 1995 Nov;11(11):1373-8. doi: 10.1089/aid.1995.11.1373.
A serum glycoprotein, vitamin D3-binding protein (Gc protein), can be converted by beta-galactosidase of stimulated B lymphocytes and sialidase of T lymphocytes to a potent macrophage-activating factor (MAF), a protein with N-acetylgalactosamine as the remaining sugar moiety. Thus, Gc protein is a precursor for MAF. Treatment of purified Gc protein with immobilized beta-galactosidase and sialidase generates an extremely high-titered MAF (GcMAF). When peripheral blood monocytes/macrophages of 46 HIV-infected patients were treated with GcMAF (100 pg/ml), the monocytes/macrophages of all patients were efficiently activated. However, the MAF precursor activity of plasma Gc protein was low in 16 (35%) of of these patients. Loss of the MAF precursor activity appeared to be due to deglycosylation of plasma Gc protein by alpha-N-acetylgalactosaminidase found in the patient blood stream. Levels of plasma alpha-N-acetylgalactosaminidase activity in individual patients had an inverse correlation with the MAF precursor activity of their plasma Gc protein. Thus, precursor activity of Gc protein and alpha-N-acetylgalactosaminidase activity in patient blood can serve as diagnostic and prognostic indices.
一种血清糖蛋白,维生素D3结合蛋白(Gc蛋白),可被活化的B淋巴细胞的β-半乳糖苷酶和T淋巴细胞的唾液酸酶转化为一种强效巨噬细胞活化因子(MAF),即一种以N-乙酰半乳糖胺作为剩余糖部分的蛋白质。因此,Gc蛋白是MAF的前体。用固定化的β-半乳糖苷酶和唾液酸酶处理纯化的Gc蛋白可产生极高滴度的MAF(GcMAF)。当用GcMAF(100 pg/ml)处理46例HIV感染患者的外周血单核细胞/巨噬细胞时,所有患者的单核细胞/巨噬细胞均被有效激活。然而,这些患者中有16例(35%)血浆Gc蛋白的MAF前体活性较低。MAF前体活性的丧失似乎是由于患者血流中发现的α-N-乙酰半乳糖胺酶使血浆Gc蛋白去糖基化所致。个体患者血浆α-N-乙酰半乳糖胺酶活性水平与其血浆Gc蛋白的MAF前体活性呈负相关。因此,患者血液中Gc蛋白的前体活性和α-N-乙酰半乳糖胺酶活性可作为诊断和预后指标。